カテゴリー： QYResearch, 世界

世界の原発性胆汁性肝硬変薬市場 2019年

【英語タイトル】Global Primary Biliary Cirrhosis Drug Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X13722）・商品コード：DATA909X13722
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：106
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、原発性胆汁性肝硬変薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ブデソニド、FFP-104、GSK-2330672、MBX-8025、NGM-282、その他に、用途別には、クリニック、病院、その他にセグメント区分し、原発性胆汁性肝硬変薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・原発性胆汁性肝硬変薬の世界市場概要
・原発性胆汁性肝硬変薬の製造コスト構成分析
・原発性胆汁性肝硬変薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・原発性胆汁性肝硬変薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・原発性胆汁性肝硬変薬のセグメント分析（種類別）
（ブデソニド、FFP-104、GSK-2330672、MBX-8025、NGM-282、その他）
・原発性胆汁性肝硬変薬のセグメント分析（用途別）
（クリニック、病院、その他）
・原発性胆汁性肝硬変薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（AlbireoPharma、CymaBay Therapeutics, Inc.、Dr. Falk Pharma GmbH、Enanta Pharmaceuticals, Inc.、GlaxoSmithKline Plc、Intercept Pharmaceuticals, Inc.、Johnson & Johnson、MediGene AG、NGM Biopharmaceuticals, Inc.、Virobay Inc.、）
・原発性胆汁性肝硬変薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Primary Biliary Cirrhosis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Primary Biliary Cirrhosis Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Primary Biliary Cirrhosis Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Primary Biliary Cirrhosis Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Primary Biliary Cirrhosis Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
AlbireoPharma
CymaBay Therapeutics, Inc.
Dr. Falk Pharma GmbH
Enanta Pharmaceuticals, Inc.
GlaxoSmithKline Plc
Intercept Pharmaceuticals, Inc.
Johnson & Johnson
MediGene AG
NGM Biopharmaceuticals, Inc.
Virobay Inc.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Budesonide
FFP-104
GSK-2330672
MBX-8025
NGM-282
Others

Segment by Application
Clinic
Hospital
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Primary Biliary Cirrhosis Drug
1.1 Definition of Primary Biliary Cirrhosis Drug
1.2 Primary Biliary Cirrhosis Drug Segment by Type
1.2.1 Global Primary Biliary Cirrhosis Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Budesonide
1.2.3 FFP-104
1.2.4 GSK-2330672
1.2.5 MBX-8025
1.2.6 NGM-282
1.2.7 Others
1.3 Primary Biliary Cirrhosis Drug Segment by Applications
1.3.1 Global Primary Biliary Cirrhosis Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Primary Biliary Cirrhosis Drug Overall Market
1.4.1 Global Primary Biliary Cirrhosis Drug Revenue (2014-2025)
1.4.2 Global Primary Biliary Cirrhosis Drug Production (2014-2025)
1.4.3 North America Primary Biliary Cirrhosis Drug Status and Prospect (2014-2025)
1.4.4 Europe Primary Biliary Cirrhosis Drug Status and Prospect (2014-2025)
1.4.5 China Primary Biliary Cirrhosis Drug Status and Prospect (2014-2025)
1.4.6 Japan Primary Biliary Cirrhosis Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Primary Biliary Cirrhosis Drug Status and Prospect (2014-2025)
1.4.8 India Primary Biliary Cirrhosis Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Primary Biliary Cirrhosis Drug
2.3 Manufacturing Process Analysis of Primary Biliary Cirrhosis Drug
2.4 Industry Chain Structure of Primary Biliary Cirrhosis Drug

3 Development and Manufacturing Plants Analysis of Primary Biliary Cirrhosis Drug
3.1 Capacity and Commercial Production Date
3.2 Global Primary Biliary Cirrhosis Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Primary Biliary Cirrhosis Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Primary Biliary Cirrhosis Drug Production and Capacity Analysis
4.2 Primary Biliary Cirrhosis Drug Revenue Analysis
4.3 Primary Biliary Cirrhosis Drug Price Analysis
4.4 Market Concentration Degree

5 Primary Biliary Cirrhosis Drug Regional Market Analysis
5.1 Primary Biliary Cirrhosis Drug Production by Regions
5.1.1 Global Primary Biliary Cirrhosis Drug Production by Regions
5.1.2 Global Primary Biliary Cirrhosis Drug Revenue by Regions
5.2 Primary Biliary Cirrhosis Drug Consumption by Regions
5.3 North America Primary Biliary Cirrhosis Drug Market Analysis
5.3.1 North America Primary Biliary Cirrhosis Drug Production
5.3.2 North America Primary Biliary Cirrhosis Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Primary Biliary Cirrhosis Drug Import and Export
5.4 Europe Primary Biliary Cirrhosis Drug Market Analysis
5.4.1 Europe Primary Biliary Cirrhosis Drug Production
5.4.2 Europe Primary Biliary Cirrhosis Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Primary Biliary Cirrhosis Drug Import and Export
5.5 China Primary Biliary Cirrhosis Drug Market Analysis
5.5.1 China Primary Biliary Cirrhosis Drug Production
5.5.2 China Primary Biliary Cirrhosis Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Primary Biliary Cirrhosis Drug Import and Export
5.6 Japan Primary Biliary Cirrhosis Drug Market Analysis
5.6.1 Japan Primary Biliary Cirrhosis Drug Production
5.6.2 Japan Primary Biliary Cirrhosis Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Primary Biliary Cirrhosis Drug Import and Export
5.7 Southeast Asia Primary Biliary Cirrhosis Drug Market Analysis
5.7.1 Southeast Asia Primary Biliary Cirrhosis Drug Production
5.7.2 Southeast Asia Primary Biliary Cirrhosis Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Primary Biliary Cirrhosis Drug Import and Export
5.8 India Primary Biliary Cirrhosis Drug Market Analysis
5.8.1 India Primary Biliary Cirrhosis Drug Production
5.8.2 India Primary Biliary Cirrhosis Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Primary Biliary Cirrhosis Drug Import and Export

6 Primary Biliary Cirrhosis Drug Segment Market Analysis (by Type)
6.1 Global Primary Biliary Cirrhosis Drug Production by Type
6.2 Global Primary Biliary Cirrhosis Drug Revenue by Type
6.3 Primary Biliary Cirrhosis Drug Price by Type

7 Primary Biliary Cirrhosis Drug Segment Market Analysis (by Application)
7.1 Global Primary Biliary Cirrhosis Drug Consumption by Application
7.2 Global Primary Biliary Cirrhosis Drug Consumption Market Share by Application (2014-2019)

8 Primary Biliary Cirrhosis Drug Major Manufacturers Analysis
8.1 AlbireoPharma
8.1.1 AlbireoPharma Primary Biliary Cirrhosis Drug Production Sites and Area Served
8.1.2 AlbireoPharma Product Introduction, Application and Specification
8.1.3 AlbireoPharma Primary Biliary Cirrhosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 CymaBay Therapeutics, Inc.
8.2.1 CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Production Sites and Area Served
8.2.2 CymaBay Therapeutics, Inc. Product Introduction, Application and Specification
8.2.3 CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Dr. Falk Pharma GmbH
8.3.1 Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Production Sites and Area Served
8.3.2 Dr. Falk Pharma GmbH Product Introduction, Application and Specification
8.3.3 Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Enanta Pharmaceuticals, Inc.
8.4.1 Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Production Sites and Area Served
8.4.2 Enanta Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.4.3 Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 GlaxoSmithKline Plc
8.5.1 GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Production Sites and Area Served
8.5.2 GlaxoSmithKline Plc Product Introduction, Application and Specification
8.5.3 GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Intercept Pharmaceuticals, Inc.
8.6.1 Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Production Sites and Area Served
8.6.2 Intercept Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.6.3 Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Johnson & Johnson
8.7.1 Johnson & Johnson Primary Biliary Cirrhosis Drug Production Sites and Area Served
8.7.2 Johnson & Johnson Product Introduction, Application and Specification
8.7.3 Johnson & Johnson Primary Biliary Cirrhosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 MediGene AG
8.8.1 MediGene AG Primary Biliary Cirrhosis Drug Production Sites and Area Served
8.8.2 MediGene AG Product Introduction, Application and Specification
8.8.3 MediGene AG Primary Biliary Cirrhosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 NGM Biopharmaceuticals, Inc.
8.9.1 NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Production Sites and Area Served
8.9.2 NGM Biopharmaceuticals, Inc. Product Introduction, Application and Specification
8.9.3 NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Virobay Inc.
8.10.1 Virobay Inc. Primary Biliary Cirrhosis Drug Production Sites and Area Served
8.10.2 Virobay Inc. Product Introduction, Application and Specification
8.10.3 Virobay Inc. Primary Biliary Cirrhosis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of Primary Biliary Cirrhosis Drug Market
9.1 Global Primary Biliary Cirrhosis Drug Market Trend Analysis
9.1.1 Global Primary Biliary Cirrhosis Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Primary Biliary Cirrhosis Drug Regional Market Trend
9.2.1 North America Primary Biliary Cirrhosis Drug Forecast 2019-2025
9.2.2 Europe Primary Biliary Cirrhosis Drug Forecast 2019-2025
9.2.3 China Primary Biliary Cirrhosis Drug Forecast 2019-2025
9.2.4 Japan Primary Biliary Cirrhosis Drug Forecast 2019-2025
9.2.5 Southeast Asia Primary Biliary Cirrhosis Drug Forecast 2019-2025
9.2.6 India Primary Biliary Cirrhosis Drug Forecast 2019-2025
9.3 Primary Biliary Cirrhosis Drug Market Trend (Product Type)
9.4 Primary Biliary Cirrhosis Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Primary Biliary Cirrhosis Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Primary Biliary Cirrhosis Drug
Table Global Primary Biliary Cirrhosis Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Primary Biliary Cirrhosis Drug Production Market Share by Types in 2018
Figure Budesonide Product Picture
Figure FFP-104 Product Picture
Figure GSK-2330672 Product Picture
Figure MBX-8025 Product Picture
Figure NGM-282 Product Picture
Figure Others Product Picture
Table Global Primary Biliary Cirrhosis Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Primary Biliary Cirrhosis Drug Consumption Market Share by Applications in 2018
Figure Clinic
Figure Hospital
Figure Others
Figure Global Primary Biliary Cirrhosis Drug Revenue (Million USD) (2014-2025)
Figure Global Primary Biliary Cirrhosis Drug Production (K Pcs) (2014-2025)
Figure North America Primary Biliary Cirrhosis Drug Market Size (Million USD) (2014-2025)
Figure Europe Primary Biliary Cirrhosis Drug Market Size (Million USD) (2014-2025)
Figure China Primary Biliary Cirrhosis Drug Market Size (Million USD) (2014-2025)
Figure Japan Primary Biliary Cirrhosis Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Primary Biliary Cirrhosis Drug Market Size (Million USD) (2014-2025)
Figure India Primary Biliary Cirrhosis Drug Market Size (Million USD) (2014-2025)
Table Primary Biliary Cirrhosis Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Primary Biliary Cirrhosis Drug in 2018
Figure Manufacturing Process Analysis of Primary Biliary Cirrhosis Drug
Figure Industry Chain Structure of Primary Biliary Cirrhosis Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Primary Biliary Cirrhosis Drug Manufacturing Plants Distribution
Table Primary Biliary Cirrhosis Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Primary Biliary Cirrhosis Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Primary Biliary Cirrhosis Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Primary Biliary Cirrhosis Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Primary Biliary Cirrhosis Drug Production Share by Manufacturers in 2018
Table Primary Biliary Cirrhosis Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Primary Biliary Cirrhosis Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Primary Biliary Cirrhosis Drug Revenue Share by Manufacturers in 2018
Table Primary Biliary Cirrhosis Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Primary Biliary Cirrhosis Drug Production by Regions 2014-2019 (K Pcs)
Table Global Primary Biliary Cirrhosis Drug Production Market Share by Regions 2014-2019
Figure Global Primary Biliary Cirrhosis Drug Production Market Share by Regions in 2018
Table Global Primary Biliary Cirrhosis Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Primary Biliary Cirrhosis Drug Revenue Market Share by Regions 2014-2019
Figure Global Primary Biliary Cirrhosis Drug Revenue Market Share by Regions in 2018
Table Global Primary Biliary Cirrhosis Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Primary Biliary Cirrhosis Drug Consumption Market Share by Regions 2014-2019
Figure North America Primary Biliary Cirrhosis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Primary Biliary Cirrhosis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Primary Biliary Cirrhosis Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Primary Biliary Cirrhosis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Primary Biliary Cirrhosis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Primary Biliary Cirrhosis Drug Production, Consumption Import and Export (K Pcs)
Figure China Primary Biliary Cirrhosis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Primary Biliary Cirrhosis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Primary Biliary Cirrhosis Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Primary Biliary Cirrhosis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Primary Biliary Cirrhosis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Primary Biliary Cirrhosis Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Primary Biliary Cirrhosis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Primary Biliary Cirrhosis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Primary Biliary Cirrhosis Drug Production, Consumption Import and Export (K Pcs)
Figure India Primary Biliary Cirrhosis Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Primary Biliary Cirrhosis Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Primary Biliary Cirrhosis Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Primary Biliary Cirrhosis Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Primary Biliary Cirrhosis Drug Market Share by Application (2014-2019)
Table AlbireoPharma Primary Biliary Cirrhosis Drug Production Sites and Area Served
Table AlbireoPharma Primary Biliary Cirrhosis Drug Product Introduction, Application and Specification
Table AlbireoPharma Primary Biliary Cirrhosis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table AlbireoPharma Primary Biliary Cirrhosis Drug Production Growth Rate (2014-2019)
Table AlbireoPharma Primary Biliary Cirrhosis Drug Production Market Share (2014-2019)
Figure AlbireoPharma Primary Biliary Cirrhosis Drug Revenue Market Share (2014-2019)
Table AlbireoPharma Primary Biliary Cirrhosis Drug Main Business and Markets Served
Table CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Production Sites and Area Served
Table CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Product Introduction, Application and Specification
Table CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Production Growth Rate (2014-2019)
Table CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Production Market Share (2014-2019)
Figure CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Revenue Market Share (2014-2019)
Table CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Main Business and Markets Served
Table Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Production Sites and Area Served
Table Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Product Introduction, Application and Specification
Table Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Production Growth Rate (2014-2019)
Table Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Production Market Share (2014-2019)
Figure Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Revenue Market Share (2014-2019)
Table Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Main Business and Markets Served
Table Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Production Sites and Area Served
Table Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product Introduction, Application and Specification
Table Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Production Growth Rate (2014-2019)
Table Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Production Market Share (2014-2019)
Figure Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Revenue Market Share (2014-2019)
Table Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Main Business and Markets Served
Table GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Production Sites and Area Served
Table GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Product Introduction, Application and Specification
Table GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Production Growth Rate (2014-2019)
Table GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Production Market Share (2014-2019)
Figure GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Revenue Market Share (2014-2019)
Table GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Main Business and Markets Served
Table Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Production Sites and Area Served
Table Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product Introduction, Application and Specification
Table Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Production Growth Rate (2014-2019)
Table Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Production Market Share (2014-2019)
Figure Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Revenue Market Share (2014-2019)
Table Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Main Business and Markets Served
Table Johnson & Johnson Primary Biliary Cirrhosis Drug Production Sites and Area Served
Table Johnson & Johnson Primary Biliary Cirrhosis Drug Product Introduction, Application and Specification
Table Johnson & Johnson Primary Biliary Cirrhosis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Johnson & Johnson Primary Biliary Cirrhosis Drug Production Growth Rate (2014-2019)
Table Johnson & Johnson Primary Biliary Cirrhosis Drug Production Market Share (2014-2019)
Figure Johnson & Johnson Primary Biliary Cirrhosis Drug Revenue Market Share (2014-2019)
Table Johnson & Johnson Primary Biliary Cirrhosis Drug Main Business and Markets Served
Table MediGene AG Primary Biliary Cirrhosis Drug Production Sites and Area Served
Table MediGene AG Primary Biliary Cirrhosis Drug Product Introduction, Application and Specification
Table MediGene AG Primary Biliary Cirrhosis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table MediGene AG Primary Biliary Cirrhosis Drug Production Growth Rate (2014-2019)
Table MediGene AG Primary Biliary Cirrhosis Drug Production Market Share (2014-2019)
Figure MediGene AG Primary Biliary Cirrhosis Drug Revenue Market Share (2014-2019)
Table MediGene AG Primary Biliary Cirrhosis Drug Main Business and Markets Served
Table NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Production Sites and Area Served
Table NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product Introduction, Application and Specification
Table NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Production Growth Rate (2014-2019)
Table NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Production Market Share (2014-2019)
Figure NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Revenue Market Share (2014-2019)
Table NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Main Business and Markets Served
Table Virobay Inc. Primary Biliary Cirrhosis Drug Production Sites and Area Served
Table Virobay Inc. Primary Biliary Cirrhosis Drug Product Introduction, Application and Specification
Table Virobay Inc. Primary Biliary Cirrhosis Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Virobay Inc. Primary Biliary Cirrhosis Drug Production Growth Rate (2014-2019)
Table Virobay Inc. Primary Biliary Cirrhosis Drug Production Market Share (2014-2019)
Figure Virobay Inc. Primary Biliary Cirrhosis Drug Revenue Market Share (2014-2019)
Table Virobay Inc. Primary Biliary Cirrhosis Drug Main Business and Markets Served
Figure Global Primary Biliary Cirrhosis Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Primary Biliary Cirrhosis Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Primary Biliary Cirrhosis Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Primary Biliary Cirrhosis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Primary Biliary Cirrhosis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Primary Biliary Cirrhosis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Primary Biliary Cirrhosis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Primary Biliary Cirrhosis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Primary Biliary Cirrhosis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Primary Biliary Cirrhosis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Primary Biliary Cirrhosis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Primary Biliary Cirrhosis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Primary Biliary Cirrhosis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Primary Biliary Cirrhosis Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Primary Biliary Cirrhosis Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Primary Biliary Cirrhosis Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Primary Biliary Cirrhosis Drug by Application (2019-2025)
Table Primary Biliary Cirrhosis Drug Distributors List
Table Primary Biliary Cirrhosis Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

AlbireoPharma、CymaBay Therapeutics, Inc.、Dr. Falk Pharma GmbH、Enanta Pharmaceuticals, Inc.、GlaxoSmithKline Plc、Intercept Pharmaceuticals, Inc.、Johnson & Johnson、MediGene AG、NGM Biopharmaceuticals, Inc.、Virobay Inc.、

★調査レポート[世界の原発性胆汁性肝硬変薬市場 2019年] (コード：DATA909X13722)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の原発性胆汁性肝硬変薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の胆石砕石器市場 2019年
    DATA909X04529 / QYResearch / 2019年11月15日 / ※本調査レポートは、胆石砕石器の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、機械式、超音波式に、用途別には、病院、医療センターにセグメント区分し、胆石砕石器の世界市場を分析しました。 ・エグゼクティブ・サマリー ・胆石砕石器の世界市場概要 ・胆石砕石器の製造コスト構成分析 ・胆石砕石器の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・胆石砕石器の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・胆石砕石器のセグメント分析（種類別） （機械式、超音波式）...The global Biliary Lithotripter market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Biliary Lithotripter volume and value at global level, regional level and company level. From a global perspective, this report represents overall Biliary Lithotripter market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Biliary Lithotripter in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Biliary Lithotripter manufacturing...
  • 胆道閉鎖症治療の世界市場：規模・現状・予測2019-2025
    DATA909X18226 / QYResearch / 2019年11月25日 / ※当調査レポートでは、胆道閉鎖症治療の世界市場について調査・分析し、胆道閉鎖症治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（薬物治療、外科治療）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の胆道閉鎖症治療市場動向 ・主要企業別マーケットシェア ・胆道閉鎖症治療の種類別市場規模2014-2019 （薬物治療、外科治療） ・胆道閉鎖症治療の用途別市場規模2014-2019 （病院、診療所、その他） ・胆道閉鎖症治療の北米市場：主要企業・種類別/用途別市場規模 ・胆道閉鎖症治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Biliary atresia or extra hepatic ductopenia is an acquired disease of the liver. This disease is characterized by the obliteration of the extra hepatic biliary system which results in obstruction of the bile flow from the liver to gall bladder.In 2018, the global Biliary Atresia Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Biliary Atresia Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biliary...
  • 世界の胆管ステント市場 2019年
    DATA909X04530 / QYResearch / 2019年11月15日 / ※本調査レポートは、胆管ステントの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、金属ステント、ポリマーステントに、用途別には、病院、医療センターにセグメント区分し、胆管ステントの世界市場を分析しました。 ・エグゼクティブ・サマリー ・胆管ステントの世界市場概要 ・胆管ステントの製造コスト構成分析 ・胆管ステントの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・胆管ステントの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・胆管ステントのセグメント分析（種類別） （金属ステント、ポリマーステント）...The global Biliary Stent market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Biliary Stent volume and value at global level, regional level and company level. From a global perspective, this report represents overall Biliary Stent market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Biliary Stent in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Biliary Stent manufacturing...

    • ◆H&Iグローバルリサーチのお客様（例）◆